Skip to main content
Tech.euFundingExplorerBeta

Psylink

Psylink is a deep-tech biotechnology company developing innovative, science-driven treatments for mental health disorders, with a focus on patients who do not respond to conventional therapies.

Psylink has raised €502k across 1 funding round from 4 investors, most recently a Pre-Seed round in Jul 2025. Based in Vilnius, Lithuania; active in Deeptech. Data as of 28 Oct 2026.

Total raised
€502k
€501,521
Funding rounds
1
Investors
4
distinct backers
Active since
2025-07
latest 2025-07

Funding by year

EUR raised per year
Psylink — funding by year — interactive chart.
Data table
Psylink — funding by year
2025€502k

Signals

High confidence
Raise-next likelihood34
base rate 24% for Pre-Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-07-29Pre-Seed€502kBSV Ventures,CoInvest Capital,FIRSTPICK,syndicate of angel investorsView deal →

Investors

4
BSV VenturesCoInvest CapitalFIRSTPICKsyndicate of angel investors

Related news

Similar companies

same sector or country

Global coverage: FundingData